drugset / Trial / NCT06531525
Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency
Phase 2
Not yet recruiting
48 enrolled
Peking University People's Hospital
Beijing Chuiyangliu Hospital · collabBeijing Friendship Hospital · collabBeijing Hospital · collabBeijing Obstetrics and Gynecology Hospital · collabChina-Japan Friendship Hospital · collabChinese PLA General Hospital · collabPeking Union Medical College Hospital · collabSichuan Academy of Medical Sciences · collabXiangya Hospital of Central South University · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
To evaluate whether low molecular heparin could improve pregnancy outcomes in pregnancies with protein S deficiency.
Timeline
- Start
- 2024-08-01
- Primary completion
- 2026-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 75 mg | Oral |
| Subject | Enoxaparin sodium | Other / unclassified | 4000 iu | Subcutaneous |